Abstract
Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Although numerous biological analyses have revealed many of the key molecules and events involved in cell signaling, an integrative view of this complicated system cannot provide a fundamental theory on the regulation of the entire network without analyzing the dynamic behavior of these molecules and events at the system level. Recent technological advances in mass spectrometry-based proteomics and bioinformatics have enabled us to obtain a networkwide description of signaling dynamics through the large-scale identification and quantification of phosphorylated molecules. Accordingly, computational modeling on the basis of dynamic proteomics data has also been applied to the network analysis of representative signaling systems such as the epidermal growth factor receptor pathway. This review focuses on the current status of quantitative proteomics technology for temporal studies of signal transduction and on the application of comprehensive signaling dynamics data to mathematical analyses of regulatory networks. The perspective on proteomics data-driven systems biology is also discussed.
Keywords: Signal transduction, quantitative proteomics, systems biology, LC-MS/MS, computational modeling
Current Bioinformatics
Title: Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology
Volume: 4 Issue: 2
Author(s): Masaaki Oyama
Affiliation:
Keywords: Signal transduction, quantitative proteomics, systems biology, LC-MS/MS, computational modeling
Abstract: Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Although numerous biological analyses have revealed many of the key molecules and events involved in cell signaling, an integrative view of this complicated system cannot provide a fundamental theory on the regulation of the entire network without analyzing the dynamic behavior of these molecules and events at the system level. Recent technological advances in mass spectrometry-based proteomics and bioinformatics have enabled us to obtain a networkwide description of signaling dynamics through the large-scale identification and quantification of phosphorylated molecules. Accordingly, computational modeling on the basis of dynamic proteomics data has also been applied to the network analysis of representative signaling systems such as the epidermal growth factor receptor pathway. This review focuses on the current status of quantitative proteomics technology for temporal studies of signal transduction and on the application of comprehensive signaling dynamics data to mathematical analyses of regulatory networks. The perspective on proteomics data-driven systems biology is also discussed.
Export Options
About this article
Cite this article as:
Oyama Masaaki, Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology, Current Bioinformatics 2009; 4 (2) . https://dx.doi.org/10.2174/157489309788184738
DOI https://dx.doi.org/10.2174/157489309788184738 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitosis-Targeting Natural Products for Cancer Prevention and Therapy
Current Drug Targets Ligand Binding Domain of Vitamin D Receptors
Current Topics in Medicinal Chemistry Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer
Current Medicinal Chemistry Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Targeting Transforming Growth Factor-beta in Colorectal Cancer: Rational and Progress
Current Pharmaceutical Design Transcriptomic Effects of Estrogen Starvation and Induction in the MCF7 Cells. The Meta-analysis of Microarray Results
Current Pharmaceutical Biotechnology Selected Heterocyclic Compounds as Antioxidants. Synthesis and Biological Evaluation
Current Topics in Medicinal Chemistry Inhibition of Receptor Tyrosine Kinases in Combination with Chemotherapy for the Treatment of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Potential Use of Food Protein-Derived Peptides in the Treatment of Inflammatory Diseases
Protein & Peptide Letters MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Immunomodulatory and Anti-inflammatory Properties of Artesunate in Experimental Colitis
Current Medicinal Chemistry P-Glycoprotein Is Not a Key Target for the Chemosensitizing Effect of 1-Phenyl-2-Decanoylamino-3-Morpholino-1-Propanol in HepG2 Cells Exposed to Doxorubicin
Drug Metabolism Letters In Vivo Transdermal Delivery of Leuprolide Using Microneedles and Iontophoresis
Current Pharmaceutical Biotechnology Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents
Current Medicinal Chemistry Phospholipase D Inhibition: Beneficial and Harmful Consequences for a Double-Dealer Enzyme
Current Enzyme Inhibition Interaction and Cytotoxic Effects of Hydrophobized Chitosan Nanoparticles on MDA-MB-231, HeLa and Arpe-19 Cell Lines
Current Topics in Medicinal Chemistry Adrenomedullin Expression in Alzheimer's Brain
Current Alzheimer Research Development and Validation of a Highly Sensitive HPLC Method for Determination of Paclitaxel in Pharmaceutical Dosage forms and Biological Samples
Current Pharmaceutical Analysis Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry Anti-cancer Nitrogen-Containing Heterocyclic Compounds
Current Organic Chemistry